CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-15 | Bitterman Kevin Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2017-05-22 | Bitterman Kevin Director | Sale | −1,000,000 | $17.00 | $17.0M | 2,797,144 |
| 2016-12-07 | Bitterman Kevin Director | Sale | −75,000 | $15.82 | $1.2M | 3,797,144 |
| 2016-12-06 | Bitterman Kevin Director | Sale | −50,000 | $15.87 | $794K | 3,872,144 |
| 2016-12-05 | Bitterman Kevin Director | Sale | −80,000 | $15.74 | $1.3M | 3,922,144 |
| 2016-11-23 | Bitterman Kevin Director | Sale | −21,480 | $15.71 | $337K | 4,002,144 |
| 2016-11-22 | Bitterman Kevin Director | Sale | −12,819 | $15.77 | $202K | 4,023,624 |
| 2016-11-16 | Bitterman Kevin Director | Sale | −30,830 | $16.30 | $503K | 4,036,443 |
| 2016-11-15 | Bitterman Kevin Director | Sale | −30,367 | $16.55 | $503K | 4,067,771 |
| 2016-11-15 | Bitterman Kevin Director | Sale | −498 | $17.78 | $9K | 4,067,273 |
| 2016-11-14 | Bitterman Kevin Director | Sale | −58,035 | $17.16 | $996K | 4,098,138 |
| 2016-09-08 | Bitterman Kevin Director | Sale | −500,000 | $16.80 | $8.4M | 4,156,173 |
| 2016-02-08 | Bitterman Kevin Director | Conversion | +2,549,435 | 2,549,435 | ||
| 2016-02-08 | Bitterman Kevin Director | Conversion | +2,021,269 | 4,570,704 | ||
| 2016-02-08 | Bitterman Kevin Director | Conversion | +85,469 | 4,656,173 | ||
| 2016-02-08 | Bitterman Kevin Director | Conversion · Series A-1 Preferred Stock | −6,628,542 | 0 | ||
| 2016-02-08 | Bitterman Kevin Director | Conversion · Series A-2 Preferred Stock | −5,255,300 | 0 | ||
| 2016-02-08 | Bitterman Kevin Director | Conversion · Series B Preferred Stock | −222,222 | 0 |
Page 1 of 1 · 18 trades